• The cannabinoid market value in 2023 was $22.23 billion and is expected to grow at a CAGR of 15.3%, resulting in an estimated market value of $60.36 billion
• The global mass spectrometry market will reach $6.77 billion in 2024 and is expected to grow at a CAGR of 6.25%, reaching $9.17 billion by 2029.
• Astrotech and subsidiary AgLAB Inc. are using mass spectrometry to boost the profitable yield of hemp and cannabis production

The United States has seen a rising awareness of the health and therapeutic benefits of cannabinoids, prompting an expected market increase of 15.3%, from $22.23 billion in 2023 to an anticipated $60.36 billion by 2030 (https://ibn.fm/xyDpO). Focused on optimizing and improving higher yields, Astrotech (NASDAQ: ASTC), a science and technology development and commercialization company, and its wholly-owned subsidiary AgLAB Inc., have developed a mass spectrometer designed for use in the hemp and cannabis market.

During the process of converting cannabis biomass into distillate, valuable cannabinoids are typically lost resulting in reduced profits. AgLAB’s Maximum Value Processing (“MVP”) Method that uses the powerful AgLAB-1000-D2 mass spectrometer to test and to accurately configure the distillation system for optimal efficiency.

The AgLAB MVP mass spectrometer and its rugged design is built to withstand the demands of the factory floor. The AgLAB-1000-D2 model offers real-time potency tests during each distillation batch cycle.  During the distillation process up to 20 tests per hour can be achieved providing almost instant, real-time results which is used to adjust parameters, such as temperature, feed rate, and vacuum, to optimize potency and increase yields for each batch. Currently testing results can take days to complete resulting in little intelligence towards processing efficiency.

“This product and method fill a void by providing an easy and accurate real-time analysis that is used to make the right adjustments and improve the yields,” an AgLAB employee, was quoted as saying in a press release about AgLAB’s 1000 series (https://ibn.fm/kD3IM).

AgLAB’s method has been extensively tested and has shown impressive results, including increased revenue and profit margins. Internal studies have shown an average revenue improvement of $5,000 per 200 kg of crude, with a 24% profit increase. Furthermore, a case study revealed a 32.9% increase in distillate mass, translating to significant weekly and annual revenue gains.

For more information, visit the company’s website at www.AstrotechCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to ASTC are available in the company’s newsroom at https://ibn.fm/ASTC

• Video streaming is expected to reach a market size of $279.5 million in 2024 and grow to $1.3 billion by 2034 due to the demand for live-streamed content and technology advancements
• Immersive content is in high demand – blending lifestyle content with entertainment elements, often through apps supporting Video-On-Demand content and traditional broadcast television
• Bravo’s acquisition of Streaming TVee’s assets further the company’s goal of advancing its video streaming and entertainment ventures with a beta launch of its TVee NOW(TM) streaming service in Q1 2024

The video streaming market is expected to keep growing in the coming years. It is estimated to grow from $279.5 million in 2024 to $1.3 billion by 2034, growing at a CAGR of 16.4%. The market’s substantial growth is due to an increased demand for live-streaming content and technological advancements that propel the expansion of the market (https://ibn.fm/Bopwf). Bravo Multinational (OTC: BRVO), a company focused on exploring opportunities in the entertainment, hospitality, and technology sectors to generate long-term value for its shareholders through high-growth business ventures, is focused on advancing video streaming and its entertainment ventures.

The key to capturing an audience’s attention in entertainment lies in delivering outstanding content and immersive experiences that seamlessly blend lifestyle and entertainment elements. Content creators can forge deeper connections with audiences and leave lasting impressions by using their expertise across various domains, including television, film, music production, live events, immersive attractions, culinary experiences, retail products, and gaming.

One of the fundamental aspects of connecting lifestyle and entertainment is understanding the pulse of the audience. Content creators must delve into their target demographic’s preferences, aspirations, and cultural nuances to craft experiences that resonate on a personal level. Whether through compelling storytelling, innovative visual techniques, or interactive elements, the goal is to transport audiences into a world where they feel fully immersed and engaged.

Television and film serve as powerful mediums for storytelling, offering a canvas for creators to explore a variety of narratives and perspectives. By producing high-quality content that reflects the richness of human experiences, filmmakers can evoke emotions, spark conversations, and inspire change. From gripping dramas to light-hearted comedies, each genre presents an opportunity to delve into different facets of lifestyle while keeping entertainment at the forefront.

Music production and behind-the-scenes content add another dimension to the immersive experience. Whether creating original soundtracks for films, curating playlists for live events, or producing albums that capture the essence of a particular lifestyle, music can evoke emotions and set the tone for memorable moments. By integrating music seamlessly into various entertainment offerings, creators can amplify the overall experience and forge deeper connections with their audience.

In February 2024, Bravo finalized a deal to acquire Streaming TVEE Inc.’s assets, allowing it to establish its flagship offering – TVee NOW(TM). The acquired assets provide the company with the technology and foundation to offer streaming services, including Video-On-Demand (“VOD”) and traditional broadcast television through a joint venture partner.

In the acquisition, Bravo obtained exclusive rights, image and likeness, label waivers, and exploitation rights for streaming 117 high-definition music and comedy performances – offering director’s cuts and multiple camera perspectives. The original content offering will allow Bravo to recreate shows in diverse formats, showcasing concert films in a new full-feature format.

Bravo’s service is set for beta launch in Q1 2024. It will be accessible across various devices, with dedicated apps on platforms like Roku, Apple, and Google Play stores. The offering only reinforces the company’s commitment to innovation and audience accessibility.

For more information, visit the company’s website at www.BravoMultinationalInc.com.

NOTE TO INVESTORS: The latest news and updates relating to BRVO are available in the company’s newsroom at https://ibn.fm/BRVO

• Demand for photovoltaic energy storage systems in the EU is growing, driven by increased demand for energy security, renewable energy sources, and grid stability
• TURB strongly positioned with patented Sunbox – an AI-powered solution for home and business photovoltaic systems
• Sunbox leverages AI-powered algorithms to optimize energy usage, maximize efficiency, and protect against price shocks
• Market size for solar energy storage batteries projected to grow from $4.40 billion in 2023 to $20.01 billion by 2030 at a CAGR of 24.2%

Demand for photovoltaic energy storage systems in the European Union is growing, driven by environmental concerns and the goal of reducing dependence on fossil fuels (https://ibn.fm/dXFtt). The adoption of solar power systems combined with battery storage is driving the surge with an emphasis on energy security, integration of renewable energy sources, and enhanced grid stability.

Turbo Energy (NASDAQ: TURB), a photovoltaic energy company based in Spain, is strongly positioned to capitalize on increased demand with its patented Sunbox – an AI-powered solution for home and commercial photovoltaic installations.

Following the recent acquisition of an international patent, Turbo Energy is now strategically determining the countries for registration. “The result will be a unique energy storage solution that we believe will provide Turbo a leading position in this industry worldwide and help pave the way towards a more sustainable and energy-efficient future,” stated Turbo as they received their Spanish patent (https://ibn.fm/LqEcR).

Sunbox helps EU policymakers meet environmental goals while incentivizing consumers through lowered energy costs, maximized efficiency, and price shock protection. The system provides a comprehensive and intelligent energy management solution, utilizing AI algorithms to optimize energy usage while ensuring a reliable power supply. Additionally, the integration of an electric vehicle charger enables seamless charging at home and increased reliability on the road.

“It is the result of years of work on power inverters’ electronics with the aim of making them more useful for the end consumer,” said Pablo de la Cuadra, Director of Development at TURB.

The projected market size for solar energy storage batteries is anticipated to expand from $4.40 billion in 2023 to $20.01 billion by 2030 at a CAGR of 24.2% over the forecast period (https://ibn.fm/ulfj9). As an industry pioneer, TURB offers next-generation solar energy batteries that leverage proprietary software, offering a competitive advantage in the growing sector. With a focus on the home energy storage market, TURB’s batteries boast capacities ranging from 2.24 kWh to 5.1 kWh in 24 and 48 volts, with the latter option available in a dual battery system.

Turbo Energy was incorporated in 2013 and operates as a subsidiary of Umbrella Solar Investment S.A. in Valencia, Spain. Led by CEO Mariano Soria, the company’s management team leverages decades of experience in renewable energy technology, finance, and sales to drive the company’s strategic vision forward in the growing energy storage market industry.

For more information, visit the company’s website at www.Turbo-e.com.

NOTE TO INVESTORS: The latest news and updates relating to TURB are available in the company’s newsroom at https://ibn.fm/TURB

Astiva Health Inc. is pioneering transformative healthcare for seniors, with a focus on enhancing mobility and promoting independence. This innovative approach places a strong emphasis on seniors as active participants in their healthcare journey, representing a shift towards a more interactive and preventive model of care.

Embracing Active Participation

Central to Astiva Health’s mission is empowering seniors to engage actively in their healthcare decisions, supporting their flourishing in later years. The CDC highlights physical activity’s crucial role in preventing chronic diseases among seniors, noting that regular physical activity can significantly reduce health risks associated with inactivity (CDC, 2020).

Tailored Exercise Programs for Active Participants

Astiva Health is committed to empowering seniors through customized exercise programs that cater to their unique needs and health goals. The organization facilitates easy access to a variety of activities, including gyms, yoga, and water aerobics. Next year, Astiva will introduce new exercise benefits, enabling members to access additional facilities, fostering an environment where seniors can actively engage in their wellness journey.

Nutritional Support and Healthy Lifestyle Choices

Astiva Health places a strong emphasis on nutritional support, offering a top-of-the-market grocery benefit of currently $100 per month to encourage seniors to choose healthy foods. This initiative ensures that grocery benefits are accessible at local markets where seniors commonly shop, making it easier for them to incorporate nutritious foods into their diet. This approach has seen nearly 100% usage by Astiva’s members, significantly simplifying the process of maintaining a healthy diet compared to other programs that may appear beneficial but are difficult to utilize.

Accessible Transportation: Empowering Mobility

To overcome mobility challenges and encourage active participation in community life, Astiva Health provides accessible transportation solutions. This initiative helps seniors maintain an active social life, access healthcare appointments, and engage in community events, directly combating isolation and promoting inclusivity.

Conclusion

Astiva Health Inc. is redefining senior healthcare by fostering an environment where seniors are recognized as active participants in their health management. Through tailored exercise programs, substantial grocery benefits encouraging healthy eating, and accessible transportation, Astiva Health empowers seniors to lead more active, healthy, and independent lives. As the global population ages, Astiva’s proactive and participatory healthcare solutions become increasingly essential for ensuring seniors can thrive in their golden years.

For more about Astiva Health’s innovative approach to senior healthcare, visit AstivaHealth.com. Astiva is dedicated to offering innovative, culturally responsive Medicare Advantage options tailored to the active lifestyles of modern seniors.

For more information, visit the company’s website at www.AstivaHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to Astiva Health are available in the company’s newsroom at https://ibn.fm/Astiva

• Clene’s recently released 2023 financial and operational updates highlight the company’s developments for the treatment of amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis
• CNM-Au8(R) functions as a neuroprotective and remyelinating therapy in neurodegenerative diseases
• Recent data from the randomized, double-blind, placebo-controlled HEALEY-ALS Platform Trial and its open-label extension, reported by Clene in December 2023, revealed encouraging outcomes on survival and delayed clinical worsening
• Clene recently provided perspectives on its achievements and the development path for CNM-Au8(R) during its participation in the 36th Annual ROTH Conference, which was held March 18-19, 2024

Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), recently announced its 2023 operational highlights for its lead candidate, along with future goals. Clene’s lead candidate, CNM-Au8(R), is a gold nanocrystal suspension that has emerged as a promising candidate for the treatment of both ALS and MS (https://ibn.fm/bzDSB).

The unique catalytic mechanism of CNM-Au8 is believed to function as a neuroprotective and remyelinating therapy in neurodegenerative diseases by: (1) driving, supporting, and maintaining beneficial metabolic and energetic cellular reactions within diseased, stressed, or damaged cells, (2) directly catalyzing the reduction of harmful reactive oxygen species (“ROS”), and (3) promoting protein homeostasis through activation of the heat shock factor-1 pathway. This pathway is known to mitigate the cytotoxic effects of misfolded and denatured proteins, which are prevalent in neurodegenerative diseases.

Clene, in collaboration with Columbia University and Synapticure, secured a substantial grant from the NIH in October 2023 to offer an Expanded Access Program (“EAP”) to people living with ALS who do not qualify for clinical trials. Additionally, recent data from the HEALEY-ALS Platform Trial and its open-label extension, reported by Clene in December 2023, revealed encouraging outcomes: CNM-Au8 30 mg treatment was associated with a substantial decrease in the long-term risk of all-cause mortality compared to placebo, a result corroborated by a notable reduction in a plasma NfL levels. Survival benefit with CNM-Au8 treatment has now been reported as a result of the open label extension of the RESCUE-ALS Phase 2 Trial, the HEALEY-ALS platform trial Regimen C, its open-label extension, and in propensity-matched control analyses of two EAPs in ALS.

Despite the FDA’s decision in late 2023 against allowing Clene to move forward with an accelerated approval pathway based on initial biomarker data, Clene is diligently preparing supplemental data to provide additional supportive biomarker, survival, and mechanistic data, to advance discussions for accelerated approval and a new drug application (“NDA”) in 2024.

CNM-Au8’s therapeutic potential extends to MS, as indicated by Clene’s January 2024 report on substantial clinical and functional improvements observed in the long-term VISIONARY-MS trial, including sustained enhancements in vision and cognition over 35 months, alongside a favorable safety profile. These advancements align with recent publications explaining CNM-Au8’s mechanism of action and brain target engagement, further establishing its credibility as a therapeutic agent.

Rob Etherington, President and CEO of Clene, said, the company will continue to advance regulatory discussions with FDA this year, talks that will include new data on biomarkers, as well as additional clinical function and survival data in people living with ALS. “Having held our initial discussion with the FDA in the fourth quarter of last year, we have a clear understanding of the additional data required to support an accelerated approval pathway filing for CNM-Au8,” Etherington explained. “We believe that we can provide additional supportive evidence to advance discussions with the FDA with the potential to file an NDA later this year.”

In addition to Clene’s updates, the company recently participated in the 36th Annual ROTH Conference, which was held March 18-19, 2024. The conference was held at The Ritz Carlton Laguna Niguel in Dana Point, California. A webcast of Clene’s presentation is available in the “Events” section of the Clene website.

For more information, visit the company’s website at www.Clene.com.

NOTE TO INVESTORS: The latest news and updates relating to CLNN are available in the company’s newsroom at https://ibn.fm/CLNN

• Lexaria, a global innovator in drug delivery platforms, recently hired a Contract Research Organization to perform their second GLP-1 human pilot study which will test a dissolvable DehydraTECH-GLP-1 oral dose formulation
• The announcement follows Lexaria’s WEIGHT-A24-1 animal study announcement examining diabetes and weight loss effects of DehydraTECH-processed GLP-1 drugs and cannabidiol alone and in combination
• The move aligns with the company’s resolve to focus on their ability to enhance the delivery of GLP-1 diabetes and obesity drugs

At the beginning of the year, Lexaria Bioscience (NASDAQ: LEXX), a global innovator for enhanced drug delivery platforms, announced its intention to double down on GLP-1 clinical studies for the 2024 calendar year. This followed a successful, active year of R&D in 2023, which saw impressive results from its patented DehydraTECH(TM) technology for the improved delivery of GLP-1 agonists (glucagon-like peptide 1) used to treat type 2 diabetes and weight loss. According to Chris Bunka, the company’s CEO, these initial results fueled the management’s optimism in this new direction, emphasizing its superior pharmacokinetics and safety/efficacy performance of GLP-1 drugs when formulated with the technology.

“Given the overwhelming interest in the GLP-1 sector, this will be a main focus. We are not at this time planning additional 2024 research in the antiviral, nicotine, or PDE5 sectors. We have solid early-stage data in each of those areas that will allow us to build upon those at the right time,” noted Mr. Bunka (https://ibn.fm/c3UuV).

In early March, Lexaria announced a 12-week animal study, WEIGHT-A24-1, to examine diabetes and weight loss effects of DehydraTECH-processed GLP-1 drugs and DehydraTECH-processed cannabidiol alone and in combination. The study, which will have 12 study arms, will involve a total rat population of 72 animals, with over 1,500 blood plasma samples collected over the duration of the study. Lexaria looks to build on the success of previous animal studies, which demonstrated, through brain tissue examination, that DehydraTECH can enable higher levels of drug delivery across the blood-brain-barrier and directly into the brain tissue (https://ibn.fm/N33Kc).

Everything is on track with this and other studies, with Lexaria hiring a contract research organization (“CRO”) to perform the second DehydraTECH-powered GLP-1 human pilot study. This randomized, crossover, placebo-controlled investigation will compare three dose formulations, each at a 7 mg semaglutide dose. So far, the manufacturing of the test articles is expected to be completed within 30 days, although Independent Review Board approval will be required before the study commences (https://ibn.fm/Vu8g6).

“DehydraTECH has previously shown an ability to improve the delivery of certain drugs destined for the bloodstream through the buccal/sublingual tissues of the mouth and throat,” noted Mr. Bunka. “If this new study is successful in demonstrating efficacy and safety, the potential for a new era in GLP-1 delivery without the need for painful injections or stomach-upsetting tablets could be within reach,” he added.

These milestones highlight Lexaria’s confidence in its DehydraTECH technology for enhancing drug delivery, and its understanding of its potential in the GLP-1 industry.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• MedCana adds to portfolio with strategic acquisition of two cannabis companies
• First acquisition represents “leap forward” in SFWJ’s commitment to innovation, excellence within the cannabis sector
• Second company holds key production, processing and exportation licenses that will strengthen MedCana’s operational chain

Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ) is growing its footprint in the cannabis space through savvy acquisitions. In the past few months, MedCana, a leading holding company in the cannabis industry, has announced two new acquisitions as the company keeps its eye on making strategic additions to its portfolio.

Last month, the company announced that it was in the final stages of negotiations to acquire its sixth cannabis company in Colombia (https://ibn.fm/6fAIH). This strategic acquisition is extremely significant because the targeted company holds a unique cannabis genetics license, which MedCana believes will revolutionize its potential to create and register unique cannabis genetic varieties for production and commercialization.

“The addition of this new company to MedCana’s portfolio represents a significant leap forward in our commitment to innovation and excellence within the cannabis sector,” said MedCana CEO Jose Gabriel Diaz. “By integrating this company’s cutting-edge genetics capabilities, MedCana will be poised to develop proprietary cannabis strains, enhancing the diversity and quality of our product offerings to meet the evolving needs of consumers and medical patients alike.”

Earlier in March, MedCana completed the previously announced acquisition plus the acquisition of a second company, bringing the number of companies in MedCana’s portfolio to nine (https://ibn.fm/PZmxC). The second company holds key production, processing and exportation licenses that will strengthen MedCana’s operational chain, supporting a seamless integration of supply from cultivation through to global distribution and ensuring the company’s position as a fully self-sufficient entity in the cannabis market.

“These acquisitions represent a monumental step towards our vision of becoming a world-leading integrated cannabis company,” said Diaz. “With seven cannabis-producing companies, one agriculture technology and infrastructure company, and one software company under our belt, MedCana is exceptionally positioned to innovate, produce and deliver high-quality cannabis products globally.”

MedCana is committed to developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. These recent acquisitions reflect the company’s focus on scientific advancements and sustainable practices as it works to achieve the broader goal of leading the cannabis industry through strategic growth and pioneering research. The company is excited about the future prospects these new assets bring to its operations and the vast opportunities for innovation they unlock.

Software Effective Solutions/MedCana is a holding company focused on developing companies in the agricultural technology and cannabis industries. As MedCana moves forward with its expansion plans, the company remains committed to delivering on its promise of building a solid foundation for future growth of its holdings.

For more information, visit the company’s website at www.MedCana.net.

NOTE TO INVESTORS: The latest news and updates relating to SFWJ are available in the company’s newsroom at https://ibn.fm/SFWJ

• Larry Fink, CEO of BlackRock, foresees a future where every financial asset is tokenized
• Tokenization promises a future where investing is more efficient, transparent, and accessible, ultimately reshaping the financial landscape
• Diamond Lake Minerals employs state-of-the-art technology to develop and support digital assets and SEC-registered security tokens – setting new industry standards for security and compliance

The cryptocurrency frenzy may overshadow a quieter yet monumental revolution in finance: the tokenization of financial assets. This movement, powered by blockchain technology, aims to digitize and securely represent assets like stocks, bonds, and real estate, eliminating intermediaries and streamlining transactions. Diamond Lake Minerals (OTC: DLMI), a multi-strategy operating company specializing in developing and supporting digital assets and SEC-registered tokens, recognizes that the future of financial markets is set to be revolutionized by tokenization.

Larry Fink, CEO of BlackRock, champions this vision, foreseeing a future where every financial asset is tokenized. Estimates suggest that by 2030, tokenized “real-world assets” could reach a staggering $10 trillion in value (https://ibn.fm/Ojajd). Real estate is a prime example of how blockchain technology could simplify and expedite transactions, reducing costs and increasing efficiency through transparent, immutable records and automated smart contracts.

However, while the potential for asset tokenization is large, it has challenges. Technological barriers and regulatory complexities pose significant hurdles. Despite this, progress is evident, with major financial institutions like UBS and HSBC exploring blockchain applications and regulators in the UK, EU, and the US creating regulatory sandboxes to test tokenization within controlled environments.

The growing acceptance signals a recognition of blockchain’s potential to transform finance. Asset tokenization represents a shift in theory, promising a future where investing is more efficient, transparent, and accessible, ultimately reshaping the financial landscape. Though obstacles remain, the trajectory towards tokenization is clear, signaling a wake-up call for those clinging to outdated practices—the future of finance is tokenized.

In recent reports from major US crypto exchanges, Coinbase Global Inc. witnessed a significant increase in net consumer transaction revenue, rising 60% in the fourth quarter compared to the previous year and 80% over the third quarter (https://ibn.fm/qt4ZS). Similarly, Robinhood Markets Inc., focusing on retail users, noted a surge in crypto notional volumes in December, marking a 242% increase from a year ago. These indicators suggest a resurgence of interest among retail traders, buoyed by the January launch of US exchange-traded funds investing directly in Bitcoin, despite previous losses incurred during the 2022 crypto-price collapse.

While retail investors are gradually returning to the market, metrics such as web searches for “Bitcoin” and app downloads for major crypto exchanges are still below peak levels seen during the last bull market. However, analysts anticipate further growth potential, especially with the upcoming Bitcoin halving expected in April, coupled with the current upward trajectory of Bitcoin prices, which have risen by more than 20% this year.

Investing in Diamond Lake Minerals is an investment in the future of asset tokenization. The company employs state-of-the-art technology to develop and support digital assets and SEC-registered security tokens – setting new industry standards for security and compliance. The company envisions a diverse portfolio, guided by its strategic partnerships and future roadmap, covering multiple industries and focused on vertical integration, digital securities, and sustainable growth.

For more information, visit the company’s website at www.DiamondLakeMinerals.com or LinkedIn page at www.LinkedIn.com/company/Diamond-Lake-Minerals/.

In addition, for information on the company’s security token SEC-regulated exchange partner INX and the development of the INX Way, visit https://www.inx.co/inx-ebook/. This free security token bible, written with the SEC on the rollout of security tokens and the future of digital assets, will greatly deepen your understanding of security tokens.

NOTE TO INVESTORS: The latest news and updates relating to DLMI are available in the company’s newsroom at https://ibn.fm/DLMI

• In February 2024, SUIC’s I.Hart Group signed an agreement with Taiwan’s largest convenience store chain, 7-Eleven Group, to distribute I.Hart’s Monga fried chicken
• That same month, SUIC and I.Hart announced the grand opening of their fourth Monga fried chicken store in Hong Kong. In tandem with the Hong Kong opening, SUIC and I.Hart announced the rollout of six Monga outlets in Fujian, China, and plans to open hundreds of Monga outlets in the U.S.
• The company’s fintech group has nine revolutionary patents with several ALL-IN-ONE products; its fintech section is fast-growing with increasing market share, and its fintech R&D group is working on revolutionary new platforms to support and finance its global merchants and franchisees

SUIC Worldwide Holdings (OTC: SUIC) provides research and development, venture financing and investment for private and public companies that develop products and services in the areas of Internet of Things, cloud computing, mobile payments, Big Data, blockchain, artificial intelligence and global franchising. The company seeks to enhance and streamline existing processes and establish new and exciting business models that will create revolutionary products and services.

SUIC is the largest shareholder and major operating partner of Beneway Holdings Group. The I.Hart Group, a subsidiary of Beneway, currently operates 150 global franchised locations under a variety of brands. It is working on integrating more successful brands into its family in Asia, such as Thai food, Hainan chicken and Asia-style BBQ skewers, and targeting 25 different brands to enter the U.S. franchise market in all 50 states. It is replicating its successful multi-branding business model and teaming up with top U.S. franchise marketing and sales agencies to expand and achieve its target of 750 franchises in the near future.

The company is headquartered in Flushing, New York, with offices in San Francisco, Taiwan and Malaysia.

Portfolio

SUIC works with Beneway in several business ventures, with focus on the following:

• Fintech – Through Boom Fintech, the major subsidiary of Beneway USA, the company holds nine revolutionary fintech patents. Boom Fintech integrates payment systems, electronic invoice devices, mobile cash registers, POS system devices and ERP, as well Big Data + AI and other services, to ALL-IN-ONE products that provide standardized intellectual property that’s modular to all industries, from chain department stores to night market vendors. Beneway Holdings Group connects borrowers and lenders, building strategic partnerships by bridging the various stakeholders to provide a holistic financial delivery ecosystem and to integrate advanced systems and finance its global merchants and franchisees.
• Food Industry Supply Chain Integration – SUIC and Beneway will partner with international trade financiers to support the huge demand for raw material import/export between the U.S. and Asia. SUIC and Beneway are looking to raise funds from an IPO and the capital markets to support mergers and acquisitions of U.S. mid- and upper-stream food industry suppliers.
• Global Franchise Expansion – Through I.Hart catering group, SUIC and Beneway are working to bring reputable and distinguished overseas food product brands to the U.S. and around the world. It is targeting 25 different brands to enter the U.S. franchise market in all 50 states, replicating its successful multi-branding business model in the U.S. It is also teaming up with several densely populated provinces and countries for aggressive execution of its global franchise expansion.
• Other Supply Chain Integration – Beneway has identified several additional industries for future expansion, including medical and health care, high-tech digital AI systems, environmental protection and energy-related production.

Market Opportunity

An analysis by Growth Market Reports, a full-service market research and business consulting organization, estimated that the value of the global Asian food market was $437.15 billion in 2022. The market value is projected to reach approximately $805.08 billion by 2031, expanding at a CAGR of 7.1% during the forecast period.

Asian cuisine is well known for its diversity, with a wide range of flavors, ingredients and cooking techniques influenced by various factors such as climate, geography, history and cultural practices. The report states that Asian food outlets are expanding at a tremendous rate in the U.S. and Europe due to rising consumer demand. Demand is driven by various factors, including the growing interest in global authentic flavors and the nutritional benefits that Asian food offers. Consumers have become increasingly exploratory with their food choices, according to the report.

While Chinese and Japanese (including sushi) restaurants are nearly ubiquitous in North American and European cities, other Asian cuisines, including Thai, Indian, Korean and Vietnamese, may be less familiar outside metro areas, presenting further growth opportunities. In addition, demand for Asian cuisine has increased due to a rapid shift toward healthy eating habits and rising Asian immigrant populations in Western countries, according to the report.

Management Team

Hank Wang is CEO of SUIC. Since 2018, he has served as CEO of the I.Hart Group. Prior to joining I.Hart, he was Secretary General of Taiwan Quantitative Hedging Development Association. He graduated from Tamkang University in Taiwan with a Bachelor of Finance degree.

Elena Lin is associate CFO of SUIC. She previously served as CEO of Monga Chicken. In 2015, she was recognized as one of Taiwan’s Top 100 Managers of the Year. She holds a master’s degree from the Kaohsiung University of Hospitality and Tourism’s Institute of Food Culture and Catering Innovation in Taiwan.

Elton Han is associate CTO of SUIC. He is also currently Director of Food and Beverage Development for the I.Hart Group. He also holds a position with the Taiwan International Young Chefs Association. He previously served as Executive Chef of Hanbilou, Huashan Guanzhi, Daye Group.

For more information, visit the company’s website at www.SinoUnitedCo.com.

NOTE TO INVESTORS: The latest news and updates relating to SUIC are available in the company’s newsroom at https://ibn.fm/SUIC

• Cannabis industry retail opportunities growing amid evolving regulations, increasing consumer demand, and shifting public attitudes
• Demand for specialized, direct-to-consumer properties includes dispensaries, manufacturing or processing centers, and distribution hubs
• ZDPY is a technology-driven property investment company that focuses on securing direct-to-consumer real estate opportunities in the regulated cannabis market
• ZDPY has recently secured and acquired investment properties in Michigan, Arizona, and Illinois with 100% occupancy and a weighted average lease term of 10+ years
• All ZDPY properties are occupied by commercial cannabis tenants, company anticipates $2.5+ million from its property investment portfolio in 2024

Changing regulations and attitudes towards cannabis use are transforming the industry, leading to new opportunities in the real estate sector. Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company, focuses on seizing direct-to-consumer real estate opportunities in the rapidly growing and regulated cannabis market.

Cannabis businesses are expanding significantly as regulations evolve, leading to an increased demand for specialized, direct-to-consumer properties that include dispensaries, manufacturing or processing centers, and distribution hubs. Real estate investors are capitalizing on this demand by acquiring properties for rental income generation while potentially realizing significant property value appreciation as the industry grows.

A case in point is Michigan, where investors, developers, and brokers swiftly pivoted to procure targeted property investments focusing on the needs of cannabis-specific businesses. Along with retail locations, other requirements in Michigan include warehouses, industrial spaces, and growing facilities (https://ibn.fm/F7hMN).

In alignment with the evolving market, ZDPY has recently secured and acquired investment properties in Michigan, Arizona, and Illinois. All properties in ZDPY’s portfolio boast 100% occupancy and a weighted average lease term of 10+ years. Each leased property is occupied by a commercial cannabis tenant, and the company anticipates more than $2.5 million from its property investment portfolio in 2024.

Zoned Properties Brokerage has closed over $80 million of commercial real estate deals nationally since 2021. The company reported revenues of $720,450 for the quarter, ending September 30, 2023 – a 17.2% year-over-year increase. In addition, ZDPY reported a positive net income of $114,523 for the September 2023 quarter compared to a net loss of $77,328 last year.

ZDPY is also leveraging digital innovation through its proprietary cannabis technology platform, called REZONE. Similar endeavors have leveraged data-driven insights, analytics, and artificial intelligence to identify potential investment properties, streamline processes, and enhance efficiency.

Overall, industry experts are optimistic about growth prospects for the industry as public attitudes shift rapidly in favor of increased liberalization. In his State of the Union Address, President Biden called for cannabis reform, specifically his intent to review marijuana rescheduling and possibly issue pardons for thousands of users convicted of possession (https://ibn.fm/15DtO).

Based in Arizona, Zoned Properties is led by Chairman and CEO Bryan McLaren, whose background in community development and strategic leadership informs the company’s forward-thinking strategy. As the cannabis industry continues its forward trajectory, Zoned Properties is favorably positioned to capitalize on real estate opportunities in the rapidly expanding market.

For more information, visit the company’s website at www.ZonedProperties.com.

NOTE TO INVESTORS: The latest news and updates relating to ZDPY are available in the company’s newsroom at https://ibn.fm/ZDPY